Mueller YK, Nguimfack A, Cavailler P, Couffignal S, Rwakimari JB, et al.
2008-01-01 • Annals of Tropical Medicine and Parasitology
2008-01-01 • Annals of Tropical Medicine and Parasitology
Between September 2003 and April 2004, the supply of antimonial drugs to Amudat Hospital, in north-eastern Uganda, was interrupted and all cases of visceral leishmaniasis presenting at t...
Alifrangis M, Nag S, Schousboe ML, Ishengoma D, Lusingu J, et al.
2014-07-24 • Emerging Infectious Diseases
2014-07-24 • Emerging Infectious Diseases
Super-resistant Plasmodium falciparum threatens the effectiveness of sulfadoxine-pyrimethamine in intermittent preventive treatment for malaria during pregnancy. It is characterized by t...
Pearce RJ, Pota H, Evehe M-SB, Ba EH, Mombo-Ngoma G, et al.
2009-04-14 • PLOS Medicine
2009-04-14 • PLOS Medicine
BACKGROUND: Although the molecular basis of resistance to a number of common antimalarial drugs is well known, a geographic description of the emergence and dispersal of resistance mutat...
Chappuis F, Mueller YK, Nguimfack A, Rwakimari JB, Couffignal S, et al.
2005-12-01 • Journal of Clinical Microbiology
2005-12-01 • Journal of Clinical Microbiology
The development of an accurate, practical, and affordable diagnostic test is essential to improve the management of visceral leishmaniasis (VL) in remote health centers. We evaluated the...